Research on antiphospholipid antibodies (aPL) and the thrombotic manifestations associated with these antibodies has grown since the description of anticardiolipin antibodies (aCL) by Harris and colleagues in the early 1980s. Antiprothrombin (aPT) antibodies are commonly detected by ELISA, using irradiated plates (aPT) or prothrombin in complex with phosphatidylserine (aPS/PT). Although aPT and/or aPS/PT are associated with antiphospholipid syndrome (APS) -related clinical features and these antibodies correlate with each other, aPT and aPS/PT belong to different populations of autoantibodies even though they can both be present in the same patient. Early studies suggested that these antibodies might be the antigenic target of lupus anticoagulant (LA) and their correlation and clinical significance is being investigated.
HarrisENGharaviAEBoeyML. Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet1983; 2: 1211–1214.
2.
HughesGRV. The antiphospholipid syndrome: ten years on. Lancet1993; 342: 341–344.
3.
GiannakopoulosBPassamFIoannouYKrilisSA. How we diagnose the antiphospholipid syndrome. Blood2009; 113: 985–994.
4.
LoeligerA. Prothrombin as a co-factor of the circulating anticoagulant in systemic lupus erythematosus?Thromb Diath Haemorrh1959; 3: 237–256.
5.
MannKGNesheimMEChurchWRHaleyPKrishnaswamyS. Surface-dependent reactions of the vitamin K‐dependent enzyme complexes. Blood1990; 76: 1–16.
6.
ArvieuxJDarnigeLCaronCReberGBensaJCColombMG. Development of an ELISA for autoantibodies to prothrombin showing their prevalence in patients with lupus anticoagulants. Thromb Haemost1995; 74: 1120–1125.
7.
GalliMBerettaGDaldossiMBeversEMBarbuiT. Different anticoagulant and immunological properties of anti-prothrombin antibodies in patients with antiphospholipid antibodies. Thromb Haemost1997; 77: 486–491.
8.
AtsumiTIekoMBertolacciniML. Association of autoantibodies against the phosphatidylserine-prothrombin complex with manifestations of the antiphospholipid syndrome and with the presence of lupus anticoagulant. Arthritis Rheum2000; 43: 1982–1993.
9.
BertolacciniMLAtsumiTKoikeTHughesGRKhamashtaMA. Antiprothrombin antibodies detected in two different assay systems. Prevalence and clinical significance in systemic lupus erythematosus. Thromb Haemost2005; 93: 289–297.
10.
BeversEMGalliMBarbuiTComfuriusPZwaalRF. Lupus anticoagulant IgG's (LA) are not directed to phospholipids only, but to a complex of lipid-bound human prothrombin. Thromb Haemost1991; 66: 629–632.
11.
RaoLVHoangADRapaportSI. Differences in the interactions of lupus anticoagulant IgG with human prothrombin and bovine prothrombin. Thromb Haemost1995; 73: 668–674.
12.
RaoLVMHoangADRapaportSI. Mechanisms and affects of the binding of lupus anticoagulant IgG and prothrombin to surface phospholipids. Blood1996; 88: 4173–4182.
13.
AkimotoTAkamaTKonoISumidaT. Relationship between clinical features and binding domains of anti-prothrombin autoantibodies in patients with systemic lupus erythematosus and antiphospholipid syndrome. Lupus1999; 8: 761–766.
14.
MaliaRGBrooksfieldCBulmanLGreavesM. Prothrombin fragment 1-2: the epitope for antiphospholipid antibody expression. Thromb Haemost1997; 171: 689–689.
15.
BajajSPRapaportSIFiererDSHerbstKDSchwartzDB. A mechanism for the hypoprothrombinemia of the acquired hypoprothrombinemia-lupus anticoagulant syndrome. Blood1983; 61: 684–692.
16.
EdsonJRVogtJMHasegawaDK. Abnormal prothrombin crossed-immunoelectrophoresis in patients with lupus inhibitors. Blood1984; 64: 807–816.
17.
FleckRARapaportSIRaoLV. Anti-prothrombin antibodies and the lupus anticoagulant. Blood1988; 72: 512–519.
18.
PermpikulPRaoLVRapaportSI. Functional and binding studies of the roles of prothrombin and beta 2-glycoprotein I in the expression of lupus anticoagulant activity. Blood1994; 83: 2878–2892.
19.
HorbachDAvan OortEDerksenRHde GrootPG. The contribution of anti-prothrombin-antibodies to lupus anticoagulant activity–discrimination between functional and non-functional anti-prothrombin-antibodies. Thromb Haemost1998; 79: 790–795.
20.
PengoVBiasoloABroccoTTonettoSRuffattiA. Autoantibodies to phospholipid-binding plasma proteins in patients with thrombosis and phospholipid reactive antibodies. Thromb Haemost1996; 75: 721–724.
21.
BertolacciniMLAtsumiTKhamashtaMAAmengualOHughesGR. Autoantibodies to human prothrombin and clinical manifestations in 207 patients with systemic lupus erythematosus. J Rheumatol1998; 25: 1104–1108.
22.
VaaralaOPuurunenMManttariMManninenVAhoKPalosuoT. Antibodies to prothrombin imply a risk of myocardial infarction in middle-aged men. Thromb Haemost1996; 75: 456–459.
23.
Hoxha A, Ruffatti A, Pittoni M, et al. The clinical significance of autoantibodies directed against prothrombin in primary antiphospholipid syndrome. Clin Chim Acta 2012.
24.
GalliMLucianiDBertoliniGBarbuiT. Anti-beta 2-glycoprotein I, antiprothrombin antibodies, and the risk of thrombosis in the antiphospholipid syndrome. Blood2003; 102: 2717–2723.
25.
ZanonESaggioratoGRamonRGirolamiAPagnanAPrandoniP. Anti-prothrombin antibodies as a potential risk factor of recurrent venous thromboembolism. Thromb Haemost2004; 91: 255–258.
26.
ForastieroRMartinuzzoMPomboG. A prospective study of antibodies to beta2-glycoprotein I and prothrombin, and risk of thrombosis. J Thromb Haemost2005; 3: 1231–1238.
27.
BizzaroNGhirardelloAZampieriS. Anti-prothrombin antibodies predict thrombosis in patients with systemic lupus erythematosus: a 15-year longitudinal study. J Thromb Haemost2007; 5: 1158–1164.
28.
PengoVBiasioloAPegoraroCCucchiniUNoventaFIlicetoS. Antibody profiles for the diagnosis of antiphospholipid syndrome. Thromb Haemost2005; 93: 1147–1152.
29.
ForastieroRMartinuzzoMIglesias VarelaMLCerratoG. Multiple (triple or quadruple) aPL positivity is much more prevalent in patients with definite antiphospholipid syndrome. Lupus2010; 19: C109 (abstract)–C109 (abstract).
30.
FunkeABertolacciniMLAtsumiTAmengualOKhamashtaMAHughesGRV. Autoantibodies to prothrombin-phosphatidylserine complex: clinical significance in systemic lupus erythematosus. Arthritis Rheum1998; 41: S240–S240.
